{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:25:19Z","timestamp":1765758319910},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T00:00:00Z","timestamp":1348185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Continuing developments in genetic testing technology together with research revealing gene-disease associations have brought closer the potential for genetic screening of populations. A major concern, as with any screening programme, is the response of the patient to the findings of screening, whether the outcome is positive or negative. Such concern is heightened for genetic testing, which it is feared may elicit stronger reactions than non-genetic testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This paper draws on thematic analysis of 113 semi-structured interviews with 39 patients being tested for familial hypercholesterolaemia (FH), an inherited predisposition to early-onset heart disease. It examines the impact of disease risk assessments based on both genetic and non-genetic information, or solely non-genetic information.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The impact of diagnostic testing did not seem to vary according to whether or not genetic information was used. More generally, being given a positive or negative diagnosis of FH had minimal discernible impact on people's lives as they maintained the continuity of their beliefs and behaviour.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The results suggest that concerns about the use of genetic testing in this context are unfounded, a conclusion that echoes findings from studies in this and other health contexts.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-13-87","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T00:14:09Z","timestamp":1348186449000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods"],"prefix":"10.1186","volume":"13","author":[{"given":"Gareth J","family":"Hollands","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Macfarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A","family":"Crook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa M","family":"Marteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,21]]},"reference":[{"key":"983_CR1","unstructured":"23andme: Company website. Available at: https:\/\/www.23andme.com. Accessed: 14th July 2011,"},{"key":"983_CR2","unstructured":"Navigenics: Company website. Available at: http:\/\/www.navigenics.com (Accessed: 14th July 2011),"},{"key":"983_CR3","unstructured":"GeneWatch UK: Revision of directive 98\/79\/EC of the European Parliament and of the Council of 27. 1998, Downloaded from: \u2264http:\/\/www.genewatch.org\/pub-396427, October on in vitro diagnostic medical devices - public consultation. GeneWatch UK response,"},{"issue":"7289","key":"983_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/464674a","volume":"464","author":"F Collins","year":"2010","unstructured":"Collins F: Has the revolution arrived?. Nature. 2010, 464 (7289): 674-675. 10.1038\/464674a.","journal-title":"Nature"},{"key":"983_CR5","volume-title":"Genetic Secrets: Protecting privacy and confidentiality in the genetic era","author":"T Murray","year":"1997","unstructured":"Murray T: Genetic exceptionalism and 'future diaries': is genetic information different from other medical information. Genetic Secrets: Protecting privacy and confidentiality in the genetic era. Edited by: Rothstein . 1997, Yale University Press, New Haven"},{"issue":"10","key":"983_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5200532","volume":"8","author":"M Broadstock","year":"2000","unstructured":"Broadstock M, Michie S, Marteau T: Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet. 2000, 8 (10): 731-738. 10.1038\/sj.ejhg.5200532.","journal-title":"Eur J Hum Genet"},{"key":"983_CR7","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511489136","volume-title":"The politics of personalised medicine","author":"A Hedgecoe","year":"2004","unstructured":"Hedgecoe A: The politics of personalised medicine. 2004, Cambridge University Press, Cambridge"},{"issue":"12","key":"983_CR8","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.socscimed.2005.04.043","volume":"61","author":"FA Miller","year":"2005","unstructured":"Miller FA, Ahern C, Ogilvie J, Giacomini M, Schwartz L: Ruling in and ruling out: Implications of molecular genetic diagnoses for disease classification. Soc Sci Med. 2005, 61 (12): 2536-2545. 10.1016\/j.socscimed.2005.04.043.","journal-title":"Soc Sci Med"},{"issue":"4","key":"983_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/03085140050174750","volume":"29","author":"C Novas","year":"2000","unstructured":"Novas C, Rose N: Genetic risk and the birth of the somatic individual. Econ Soc. 2000, 29 (4): 485-513. 10.1080\/03085140050174750.","journal-title":"Econ Soc"},{"issue":"3","key":"983_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1176\/appi.ps.57.3.382","volume":"57","author":"JC Phelan","year":"2006","unstructured":"Phelan JC, Yang LH, Cruz-Rojas R: Effects of attributing serious mental illnesses to genetic causes on orientations to treatment. Psychiatr Serv. 2006, 57 (3): 382-387. 10.1176\/appi.ps.57.3.382.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"983_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/tc.12.2.227","volume":"12","author":"AJ Wright","year":"2003","unstructured":"Wright AJ, Weinman J, Marteau TM: The impact of learning of a genetic predisposition to nicotine dependence: an analogue study. Tob Control. 2003, 12 (2): 227-230. 10.1136\/tc.12.2.227.","journal-title":"Tob Control"},{"issue":"21","key":"983_CR12","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/eurheartj\/ehn448","volume":"29","author":"A Rees","year":"2008","unstructured":"Rees A: Familial hypercholesterolaemia: underdiagnosed and undertreated. Eur Heart J. 2008, 29 (21): 2583-2584. 10.1093\/eurheartj\/ehn448.","journal-title":"Eur Heart J"},{"key":"983_CR13","volume-title":"Familial hypercholesterolaemia. NICE guideline 71","author":"National Institute for Clinical Excellence (NICE)","year":"2008","unstructured":"National Institute for Clinical Excellence (NICE): Familial hypercholesterolaemia. NICE guideline 71. 2008, NICE, London"},{"issue":"1","key":"983_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1743-7075-8-23","volume":"8","author":"A Fahed","year":"2011","unstructured":"Fahed A, Nemer G: Familial Hypercholesterolemia: The Lipids or the Genes?. Nutr Metab. 2011, 8 (1): 23-10.1186\/1743-7075-8-23.","journal-title":"Nutr Metab"},{"issue":"2","key":"983_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1359105302007002455","volume":"7","author":"V Senior","year":"2002","unstructured":"Senior V, Smith JA, Michie S, Marteau TM: Making sense of risk: An interpretative phenomenological analysis of vulnerability to heart disease. J Health Psychol. 2002, 7 (2): 157-168. 10.1177\/1359105302007002455.","journal-title":"J Health Psychol"},{"issue":"4","key":"983_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/1363459309103915","volume":"13","author":"K Weiner","year":"2009","unstructured":"Weiner K: The tenacity of the coronary candidate: how people with familial hypercholesterolaemia construct raised cholesterol and coronary heart disease. Health. 2009, 13 (4): 407-427.","journal-title":"Health"},{"issue":"5","key":"983_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000121398","volume":"11","author":"K Weiner","year":"2008","unstructured":"Weiner K, Durrington PN: Patients' understandings and experiences of familial hypercholesterolemia. Community Genet. 2008, 11 (5): 273-282. 10.1159\/000121398.","journal-title":"Community Genet"},{"key":"983_CR18","unstructured":"NVivo qualitative data analysis software (Version 8). 2008, QSR International Pty Ltd"},{"issue":"5","key":"983_CR19","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.socscimed.2010.05.018","volume":"71","author":"CM Will","year":"2010","unstructured":"Will CM, Armstrong D, Marteau TM: Genetic unexceptionalism: Clinician accounts of genetic testing for familial hypercholesterolaemia. Soc Sci Med. 2010, 71 (5): 910-917. 10.1016\/j.socscimed.2010.05.018.","journal-title":"Soc Sci Med"},{"key":"983_CR20","volume-title":"The Self-Regulation of Health and Illness Behaviour","year":"2003","unstructured":"The Self-Regulation of Health and Illness Behaviour. Edited by: Cameron LD, Leventhal H. 2003, Routledge, London"},{"key":"983_CR21","doi-asserted-by":"crossref","unstructured":"Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, Attwood S, Hollands GJ: Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev. 2010, CD007275-10","DOI":"10.1002\/14651858.CD007275.pub2"},{"key":"983_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/1471-2458-11-603","volume":"11","author":"RE Collins","year":"2011","unstructured":"Collins RE, Lopez LM, Marteau TM: Emotional impact of screening: a systematic review and meta-analysis. BMC Publ Health. 2011, 11: 603-10.1186\/1471-2458-11-603.","journal-title":"BMC Publ Health"},{"key":"983_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/GIM.0b013e3181f710ca","volume":"13","author":"R Collins","year":"2011","unstructured":"Collins R, Wright A, Marteau T: Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review. Genet Med. 2011, 13: 273-277. 10.1097\/GIM.0b013e3181f710ca.","journal-title":"Genet Med"},{"issue":"7649","key":"983_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/bmj.39514.494167.AD","volume":"336","author":"JN Johnson","year":"2008","unstructured":"Johnson JN: Should we screen for aortic aneurysm? No. BMJ. 2008, 336 (7649): 863-10.1136\/bmj.39514.494167.AD.","journal-title":"BMJ"},{"issue":"3","key":"983_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1056\/NEJMe0903449","volume":"361","author":"RA Kane","year":"2009","unstructured":"Kane RA, Kane RL: Effect of Genetic Testing for Risk of Alzheimer's Disease. N Engl J Med. 2009, 361 (3): 298-299. 10.1056\/NEJMe0903449.","journal-title":"N Engl J Med"},{"issue":"3","key":"983_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/01.GIM.0000068986.03217.BB","volume":"5","author":"R Gramling","year":"2003","unstructured":"Gramling R, Nash J, Siren K, Culpepper L: Predictive genetics in primary care: Expectations for the motivational impact of genetic testing affects the importance family physicians place on screening for familial cancer risk. Genet Med. 2003, 5 (3): 172-175. 10.1097\/01.GIM.0000068986.03217.BB.","journal-title":"Genet Med"},{"issue":"2","key":"983_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJM200007133430213","volume":"343","author":"NA Holtzman","year":"2000","unstructured":"Holtzman NA, Marteau TM: Will genetics revolutionize medicine?. N Engl J Med. 2000, 343 (2): 141-144. 10.1056\/NEJM200007133430213.","journal-title":"N Engl J Med"},{"issue":"2","key":"983_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2010.01.010","volume":"210","author":"A Garcia-Rios","year":"2010","unstructured":"Garcia-Rios A, Perez-Martinez P, Fuentes F, Mata P, Lopez-Miranda J, Alonso R, Rodriguez F, Garcia-Olid A, Ruano J, Ordovas JM, et al: Genetic variations at ABCG5\/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia. Atherosclerosis. 2010, 210 (2): 486-492. 10.1016\/j.atherosclerosis.2010.01.010.","journal-title":"Atherosclerosis"},{"issue":"1","key":"983_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","volume":"168","author":"D Marks","year":"2003","unstructured":"Marks D, Thorogood M, Neil HAW, Humphries SE: A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis. 2003, 168 (1): 1-14. 10.1016\/S0021-9150(02)00330-1.","journal-title":"Atherosclerosis"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-13-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-13-87\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-13-87","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-13-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:15:46Z","timestamp":1630527346000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-13-87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-13-87","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,21]]},"assertion":[{"value":"19 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"87"}}